TABLE III.
A. hMSC |
||||||||
---|---|---|---|---|---|---|---|---|
Donor set 1 |
Donor set 2 |
Donor set 3 |
Donor set 4 |
|||||
Gene | Day 3 | Day 7 | Day 3 | Day 7 | Day 7 | Day 14 | Day 7 | Day 14 |
Collagen I | 1.01 ± 0.15 | 1.11 ± 0.13 | 1.1 ± 0.24 | 1.6 ± 0.27 | 1.1 ± 0.21 | 0.9 ± 0.48 | 1.0 ± 0.19 | 0.7 ± 0.16 |
Collagen III | 1.05 ± 0.06 | 1.2 ± 0.30 | 1.7 ± 0.66 | 1.4 ± 0.49 | 1.0 ± 0.17 | 15 ± 032 | 0.9 ±0.12 | 1.0 ± 0.32 |
Tenascin C | 0.49 ± 0.07% | 1.03 ± 0.30 | 10 ± 0.4 | 1.2 ± 0.21 | 0.90 ± 0.19 | 1.4 ± 039 | 0.5 ± 0.22 | 0.7 ± 0.40 |
Tenomodulin | ND | ND | 5.2 ± 1.96* | 4.9 ± 20* | 1.0 ± 0.26 | 0.6 ± 020 | 4.2 ± 1.75* | 2.2 ± 0.20* |
Aggrecan | 0.95 ± 1.13 | 0.80 ± 0.09 | 1.4 ± 0.25 | 2.5 ± 0.72* | 1.0 ± 0.39 | 0.7 ± 037 | 1.5 ± 0.15* | 3.8 ± 1.13* |
TIMP-3 | 1.29 ± 0.87 | 0.77 ± 0.2I | 0.9 ± 0.21 | 1.5 ± 0.38 | 1.4 ± 0.22 | 0.8 ± 032 | 0.8 ± 0.05 | 0.9 ± 0.16 |
MMP-1 | ND | ND | 1.4 ± 0.16 | 1.0 ± 0.45 | 2.6 ± 0.11* | 1.7 ± 0.47 | 1.7 ± 1.12 | 0.9 ± 0.15 |
MMP-3 | ND | ND | 1.8 ± 0.70 | 0.8 ± 0.20 | 1.7 ± 0.42 | 12 ± 032 | 1.5 ± 0.55 | 0.8 ± 0.11 |
MMP-13 | ND | 0.85 ± 0.28 | 1.0 ± 0.62 | 1.1 ± 0.47 | 2.0 ± 0.39* | 05 ± 034 | 0.8 ± 0.14 | 0.8 ± 0.14 |
ADAMTS-4 | 1.20 ± 0.24 | 1.02 ± 0.03 | 1.0 ± 0.39 | 1.7 ± 0.58 | 1.7 ± 0.23 | 1.0 ± 039 | 1.0 ± 0.14 | 0.8 ± 0.25 |
ADAMTS-5 | 1.07 ± 0.08 | 1.19 ± 0.52 | 1.7 ± 0.85 | 3.0 ± 1.21* | 1.8 ± 0.35* | 1.1 ± 039 | 1.6 ± 0.29* | 1.5 ± 0.30 |
| ||||||||
B. hHT | ||||||||
| ||||||||
Collagen I | 0.75 ± 0.11* | l.03 ± 0.28 | 1.19 ± 0.25 | 1.39 ± 0.52 | 1.33 ± 0.44 | 3.95 ± 1.49* | 1.50 ± 0.54 | 0.91 ± 0.27 |
Collagen III | 0.67 ± 0.09 | 1.11 ± 0.30 | 1.75 ± 0.46 | 1.23 ± 0.32 | 1.41 ± 0.54 | 1.63 ± 0.64* | 1.51 ± 0.08 | 1.07 ± 0.64 |
Tenascin C | l.32 ± 0.48 | 1.14 ± 0.33 | 2.19 ± 0.96 | 1.87 ± 0.35* | 0.95 ± 0.41 | 1.89 ± 1.18 | 2.09 ± 0.84 | 2.05 ± 0.35 |
Tenomodulin | ND | ND | ND | ND | ND | ND | 1.39 ± 0.90 | 2.80 ± 1.52 |
Aggrecan | 2.33 ± 1.90 | 0.84 ± 0.08 | 1.24 ± 0.40 | 1.04 ± 0.42 | 0.77 ± 039 | 0.62 ± 0.23 | 1.47 ± 0.43 | 0.74 ± 0.46 |
TIMP-3 | 2.12 ± 1.93 | 0.94 ± 0.33 | 1.85 ± 1.12 | 0.95 ± 0.20 | 2.06 ± 0.43* | 2.66 ± 0.64* | 2.27 ± 0.82 | 0.74 ± 0.30 |
MMP-1 | 4.32 ± 0.39# | 10.01 ± 4.73* | 0.65 ± 0.62 | 1.11 ± 0.08 | 1.16 ± 020 | 3.72 ± 0.77% | 4.14 ± 0.94* | 0.61 ± 0.30 |
MMP-3 | ND | 3.51 ± 1.34* | 1.37 ± 0.92 | 1.14 ± 0.14 | 1.90 ± 022* | 0.90 ± 0.23 | 2.06 ± 0.67 | 0.94 ± 0.45 |
MMP-13 | 8.07 ± 0.71# | 16.43 ± 5.15% | 1.0 ± 0.62 | 1.33 ± 0.26 | 1.05 ± 0.14 | 2.12 ± 0.29% | 3.16 ± 0.98* | 1.61 ± 0.11 |
ADAMTS-4 | 1.29 ± 0.45 | 3.08 ± 1.04* | 2.53 ± 0.94 | 1.43 ± 0.21 | 1.61 ± 0.19* | 2.03 ± 0.41* | 2.47 ± 1.01 | 0.98 ± 0.42 |
ADAMTS-5 | 0.44 ± 0.15 | 0.53 ± 0.25 | 0.54 ± 0.44 | 0.90 ± 0.24 | 0.64 ± 0.17 | 120 ± 0.37 | 1.18 ± 0.46 | 0.73 ± 0.29 |
Transcript levels expressed as relative compared to non co-cultured control cell populations. Normalized to B2M or GAPDH.
P < 0.05,
P < 0.01,
P < 0.001.